Table 2 |
|||||
|
Subjective measures assessed by visual analogue scale (0–100 mm) |
|||||
| Parameters |
Baseline (n = 16) |
6 weeks (n = 15) |
10 weeks (n = 13) |
18 weeks (n = 14) |
32 weeks (n = 11) |
|
|
|||||
| Fatigue |
55 ± 21 |
46 ± 30 |
44 ± 28 |
45a ± 22 |
41a ± 29 |
| Pain |
49 ± 28 |
31 ± 32 |
32 ± 29 |
39 ± 25 |
34 ± 26 |
| Patient assessmentb |
62 ± 29 |
38a ± 30 |
49 ± 23 |
48a ± 31 |
40a ± 28 |
| Physician assessmentc |
56 ± 16 |
30a ± 22 |
36a ± 14 |
31a ± 20 |
26a ± 12 |
|
|
|||||
|
Results are given in mean ± standard deviation. aDenotes statistical significance of the observed median change-from-baseline value with P ≤ 0.05 by Wilcoxon signed rank test. bPatient self-assessment of overall well-being. cPhysician global assessment of patient's overall well-being. |
|||||
|
Steinfeld et al. Arthritis Research & Therapy 2006 8:R129 doi:10.1186/ar2018 |
|||||